The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 29, 2015
Filed:
May. 05, 2011
Applicants:
Charles E. Diliberti, Montclair, NJ (US);
Anu Mahashabde, Kendall Park, NJ (US);
Inventors:
Charles E. DiLiberti, Montclair, NJ (US);
Anu Mahashabde, Kendall Park, NJ (US);
Assignee:
TEVA WOMEN'S HEALTH, INC., Woodcliff Lake, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 6/06 (2006.01); A61K 31/00 (2006.01); A61K 31/137 (2006.01); A61K 31/465 (2006.01); A61K 31/515 (2006.01); A61K 31/522 (2006.01); A61K 31/551 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/00 (2013.01); A61K 31/137 (2013.01); A61K 31/465 (2013.01); A61K 31/515 (2013.01); A61K 31/522 (2013.01); A61K 31/551 (2013.01); A61M 31/002 (2013.01); A61M 37/00 (2013.01);
Abstract
The present invention is directed to methods of reducing symptoms associated with an abrupt reduction in an endogenous or exogenous chemical in subjects, the methods comprising: (a) administering to the subject a single dosage form comprising an active agent, wherein the release rate of the active agent from the single dosage form tapers throughout the administration; and (b) removing the single dosage form from the subjects after the release rate of the active agent is at or below a terminal symptom threshold level.